Pulmonary Mycobacterium Simiae infection and HTLV1 infection: An incidental co-infection or a predisposing factor?

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 65, Issue 2, 2006, Pages 106-109

  Mirsaeidi, S M ^a   Tabarsi, P ^a   Mardanloo, A ^a   Ebrahimi, G ^a   Amiri, M ^a   Farnia, P ^a   Sheikhleslami, M ^a   Bakayev, V ^a   Mohammadi, F ^a   Mansouri, S D ^a   Masjedi, M R ^a   Velayati, A A ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Human T lymphothropic virus Type I; Mycobacterium simiae; Pulmonary infection

Indexed keywords

AMIKACIN; CIPROFLOXACIN; CLARITHROMYCIN; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ANAMNESIS; ANTIBODY DETECTION; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BRONCHOSCOPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG SUBSTITUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN TISSUE; IMMUNE RESPONSE; LABORATORY TEST; LUNG BIOPSY; LUNG INFECTION; LUNG LAVAGE; LUNG TUBERCULOSIS; MYCOBACTERIUM SIMIAE; SEROLOGY; SPUTUM CULTURE; SUPERINFECTION; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TREATMENT RESPONSE; WESTERN BLOTTING;

EID: 33747040558     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2006.573     Document Type: Article

References (18)

1. Brunello F, Ligozzi M, Cristelli E, Bonora S, Tortoli E, Fontana R. Identification of 54 mycobacterial species by PCR-restriction fragment length polymorphism analysis of the hsp65 gene. J Clin Microbiol 2001; 39: 2799-806.
2. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 1997; 156: S1-25
3. Al-Abdely HM, Revankar SG, Graybill JR. Disseminated Mycobacterium simiae infection in patients with AIDS. J Infect 2000; 41: 143-7.
4. Braun-Saro B, Esteban J, Jimenez S, Castrillo JM, Fernandez-Guerrero ML. Mycobacterium simiae Infection in an Immunocompromised Patient without Acquired Immunodeficiency Syndrome. Clin Infect Dis 2002 1; 34: E26-E27.
5. Kuipers EJ, Hazenberg HJ, Ploeger B, Smit FW, de JA. Nontuberculous mycobacterial sternal osteomyelitis in a patient without predisposing condition. Neth J Med 1991; 38: 122-5.
6. Menard O, Tanguy B, Ahmed Z, Caligaris P, Desnanot J. [Severe pulmonary mycobacteriosis caused by Mycobacterium simiae]. Rev Mal Respir 1987; 4: 327-9.
7. Mori T. Acid-fast bacilli detected in umbilical codes and skins of human at cases of surgical operation. Nippon Rai Gakkai Zasshi 1990; 59: 98-112.
8. Piquero J, Casals VP, Higuera EL, Yakrus M, Sikes D, de Waard JH. Iatrogenic Mycobacterium simiae skin infection in an immunocompetent patient. Emerg Infect Dis 2004; 10: 969-70.
9. Sampaio JL, Artiles N, Pereira RM, Souza JR, Leite JP. Mycobacterium simiae infection in a patient with acquired immunodeficiency syndrome. Braz J Infect Dis 2001; 5: 352-5.
10. Conger N, O'Connell R, Laurel V, et al. Mycobacterium simae outbreak associated with a hospital water supply. Infect Control Hosp Epidemiol 2004; 25: 1050-5.
11. Porteous NB, Redding SW, Jorgensen JH. Isolation of non-tuberculosis mycobacteria in treated dental unit waterlines. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98: 40-4.
12. Yoshimura K, Imao M, Goto H, et al. [A case of pulmonary infection due to Mycobacterium simiae]. Nihon Kokyuki Gakkai Zasshi 2005; 43: 32-6.
13. Matsuyama W, Mizoguchi A, Iwami F, Koreeda Y, Wakimoto J, Kanazawa H, et al. Clinical investigation of pulmonary Mycobacterium avium complex infection in human T lymphotrophic virus type I carriers. Thorax 2000; 55: 388-92.
14. Matsuyama W, Kubota R, Hamasaki T, et al. Enhanced inhibition of lymphocyte activation by Mycobacterium avium complex in human T lymphotrophic virus type I carriers. Thorax 2001; 56: 394-7.
15. Goon PK, Igakura T, Hanon E, et al. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I. J Immunol 2004; 172: 1735-43.
16. Santos SB, Porto AF, Muniz AL, de Jesus AR, Magalhaes E, Melo A, et al. Exacerbated inflammatory cellular immune response characteristics of HAM/ TSP is observed in a large proportion of HTLV-I asymptomatic carriers. BMC Infect Dis 2004; 4: 7.
17. Yamazato Y, Miyazato A, Kawakami K, Yara S, Kaneshima H, Saito A. High expression of p40(tax) and pro-inflammatory cytokines and chemokines in the lungs of human T-lymphotropic virus type 1-related bronchopulmnonary disorders. Chest 2003; 124: 2283-92.
18. Sabouri AH, Saito M, Usuku K, et al. Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals. J Gen Virol 2005; 86: 773-81.